Dr. Stephen D. Barnhill - Special Medical Adviser
Dr. Stephen D. Barnhill, MD is currently the Chairman & CEO of Apollon Formularies, plc. (London, UK) (AQSE:APOL), Chairman and CEO of Apollon Formularies, Inc. (USA), President and Board Member Apollon Formularies Jamaica, Ltd. (Jamaica), and Chairman and CEO of Doc’s Place International, Inc.
Dr. Barnhill is a Medical Doctor specializing in Cannabinoid and Mycomedicinal Therapeutics, Drug Discovery and Artificial Intelligence, and has completed a Clinical Fellowship in Laboratory Medicine (Clinical Pathology) at the Medical University of South Carolina (MUSC).
Previously, Dr. Barnhill was Founder, Chairman and CEO of both private and public companies, including Founder, Chairman, and CEO of BCL laboratories, LLC with operations in southeastern US, which was acquired by Corning–MetPath now Quest Diagnostics, the largest clinical laboratory in the world. After the acquisition, he served as a Medical Director for that Quest Diagnostics location for approximately 5 years. Dr. Barnhill was Founder, Chairman and CEO of National Medical Specialty Labs which was acquired by Horus Therapeutics Inc. (a New York Pharmaceutical Company) and Chairman and CEO of Health Discovery Corporation, a US publicly traded international biotech company, from inception to profitability.
Gene Selection for Cancer Classification using Support Vector Machines (Cited by nearly 10,000 publications) Journal, Machine Learning: Isabelle Guyon, Jason Weston, Stephen Barnhill & Vladimir Vapnik MORE
As CEO, Dr. Barnhill has negotiated and executed deals with many companies including Pfizer, Abbot, Corning-MetPath, Quest Diagnostics, Clarient, LabCorp, NeoGenomics, Bruker and others.
Dr. Barnhill is a pioneer in artificial intelligence machine learning (pattern recognition algorithms) in medicine and is an Inventor on more than 80 international patents including neural networks and support vector machines including the Hallmark SVM-RFE technique now cited by more than 10,000 publications. His patents were part of the intellectual property portfolio that won First Place out of 1,600 publicly traded companies and was awarded the prestigious MICO award from MDB Capital for the most disruptive and market changing intellectual property portfolio. The neural network patents, with Dr Barnhill as an inventor, were acquired by Johnson & Johnson.
Dr. Barnhill has been an inventor on patents related to laboratory developed tests (LDT’s) and tumor markers, as well as, diagnostic test development relating to cancers of the prostate, pancreas, breast and ovary, cytogenetics, flow cytometry, Florescence In Situ Hybridization (FISH), and imaging in digital mammography, funduscopic analysis of macular degeneration (AMD) and SVM for melanoma detection.
Dr. Barnhill has been accepted and admitted as a Member or Fellow of the following organizations: the American College of Physician Inventors, the American College of International Physicians, the American Medical Association, the American College of Physician Executives, the American Association of Artificial Intelligence, the American College of Managed Care Medicine, the Association of Clinical Scientists, the American Society of Contemporary Medicine and Surgery, the American Society of Law, Medicine and Ethics, the Southern Medical Society, the American Federation for Clinical Research, the National Federation of Catholic Physicians and the Society of Cannabis Clinicians.